Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

Oropharyngeal candidiasis is a common opportunistic mucosal infection of the oral cavity, mainly caused by an overgrowth of Candida albicans. This infection can inhibit nutritional intakes and strongly affect quality of life. To date, standard therapeutic strategies involving the administration of a...

Full description

Bibliographic Details
Main Authors: Elena Roselletti, Samuele Sabbatini, Nathalie Ballet, Stefano Perito, Eva Pericolini, Elisabetta Blasi, Paolo Mosci, Amélie Cayzeele Decherf, Claudia Monari, Anna Vecchiarelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Microbiology
Subjects:
oropharyngeal candidiasis
oral infections
probiotics
Saccharomyces cerevisiae
Candida albicans
yeasts
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01469/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.01469/full

Similar Items